Skincare company Obagi Medical has announced the launch of its Retinol + PHA Refining Night Cream.
Now available through aesthetic distributor Healthxchange, the cream is formulated with 0.3% retinol and Polyhydroxy Acid (PHA) to promote a more even-looking complexion, according to the company.
Obagi Medical has shared clinical trial results indicating that, out of 30 participants, 90% observed a reduction in the appearance of blemishes within four weeks, with a 10% visible improvement in skin tone evenness.
Simone Shoffman, head of education at Healthxchange, commented, “Obagi Medical is renowned for retinols that cause minimal irritation with maximum proven clinical results, this is due to an elegant microencapsulation formulation. This balanced formulation offers an effective yet tolerable entry point for retinol newcomers as well as those who are more hesitant due to skin sensitivity.”
